Oligonucleotide Synthesis Market Size, Share, Trends, Growth 2032

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global oligonucleotide synthesis market,2016-2026 (USD Million)
  • 2.2. Global oligonucleotide synthesis market: snapshot
•  
• Chapter 3. Oligonucleotide Synthesis Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market Drivers
    • 3.2.1. Global oligonucleotide synthesis market drivers: impact analysis
    • 3.2.2. Increasing government investments and R&D expenditure in pharma and biotech companies
    • 3.2.3. Strong pipeline of antisense oligonucleotides
    • 3.2.4. Large number of players operating in the market
  • 3.3. Market Restraints
    • 3.3.1. Global oligonucleotide synthesis market restraints: impact analysis
    • 3.3.2. In-house development of oligonucleotides hindering revenue growth
    • 3.3.3. Price erosion of synthesized oligonucleotides
  • 3.4. Opportunities
    • 3.4.1. Growing focus on personalized medicine
    • 3.4.2. Emerging Asian market
  • 3.5. Porter’s Five Forces Analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. Market attractiveness analysis, by offering
    • 3.6.2. Market attractiveness analysis, by application
    • 3.6.3. Market attractiveness analysis, by end-user
    • 3.6.4. Market attractiveness analysis, by region
•  
• Chapter 4. Global Oligonucleotide Synthesis Market - Competitive Landscape
  • 4.1. Company market share analysis
    • 4.1.1. Global oligonucleotide synthesis market: company market share, 2017
  • 4.2. Strategic development
    • 4.2.1. Acquisitions & mergers
    • 4.2.2. New therapy launch
    • 4.2.3. Agreements, partnerships, collaborations, and joint ventures
    • 4.2.4. Research and development and regional expansion
•  
• Chapter 5. Global Oligonucleotide Synthesis Market - Offering Segment Analysis
  • 5.1. Global oligonucleotide synthesis market: offering overview
    • 5.1.1. Global oligonucleotide synthesis market revenue share, by offering, 2016 and 2026
  • 5.2. Equipment
    • 5.2.1. Global oligonucleotide synthesis market for equipment, 2016 - 2026 (USD Million)
  • 5.3. Reagents and Consumables
    • 5.3.1. Global oligonucleotide synthesis market for reagents and consumables,2016-2026 (USD Million)
  • 5.4. Synthesized Oligonucleotides
    • 5.4.1. Global oligonucleotide synthesis market for synthesized oligonucleotides, 2016 - 2026 (USD Million)
    • 5.4.1.1. Product
      • 5.4.1.1.1. Global synthesized oligonucleotides market for product, 2016-2026(USD Billion)
    • 5.4.1.2. Services
      • 5.4.1.2.1. Global synthesized oligonucleotides market for services, 2016-2026(USD Billion)
•  
• Chapter 6. Global Oligonucleotide Synthesis Market - Application Analysis
  • 6.1. Global oligonucleotide synthesis market: Application Overview
    • 6.1.1. Global oligonucleotide synthesis market revenue share, by application, 2016 and 2026
  • 6.2. Research
    • 6.2.1. Global oligonucleotide synthesis market for research, 2016-2026 (USD Million)
      • 6.2.1.1. Polymerase Chain Reaction
        • 6.2.1.1.1. Global research market for polymerase chain reaction, 2016-2026(USD Billion)
      • 6.2.1.2. qPCR
        • 6.2.1.2.1. Global research market for qPCR, 2016-2026(USD Billion)
      • 6.2.1.3. Next Generation Sequencing
        • 6.2.1.3.1. Global research market for next-generation sequencing, 2016-2026(USD Billion)
      • 6.2.1.4. Others
        • 6.2.1.4.1. Global research market for others, 2016-2026(USD Billion)
  • 6.3. Therapeutics
    • 6.3.1. Global oligonucleotide synthesis market for therapeutics, 2016-2026 (USD Million)
      • 6.3.1.1. Antisense Oligonucleotides
        • 6.3.1.1.1. Global therapeutics market for antisense oligonucleotides, 2016-2026(USD Billion)
      • 6.3.1.2. RNAi
        • 6.3.1.2.1. Global therapeutics market for RNAi, 2016-2026(USD Billion)
      • 6.3.1.3. Nucleic Acid Aptamers
        • 6.3.1.3.1. Global therapeutics market for nucleic acid Aptamers, 2016-2026(USD Billion)
      • 6.3.1.4. Immunotherapy Applications
        • 6.3.1.4.1. Global therapeutics market for immunotherapy application, 2016-2026(USD Billion)
  • 6.4. Diagnostics
    • 6.4.1. Global oligonucleotide synthesis market for diagnostics, 2016-2026 (USD Million)
•  
• Chapter 7. Global Oligonucleotide Synthesis Market - End-user Analysis
  • 7.1. Global oligonucleotide synthesis market: end-user overview
    • 7.1.1. Global oligonucleotide synthesis market revenue share, by end-user, 2017 and 2026
  • 7.2. Academic Research Institute
    • 7.2.1. Global oligonucleotide synthesis market for academic research institute, 2016-2026 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Global oligonucleotide synthesis market for diagnostic laboratories, 2016 - 2026 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global oligonucleotide synthesis market for pharmaceutical and biotechnology companies, 2016-2026 (USD Million)
  • 7.5. Others
    • 7.5.1. Global oligonucleotide synthesis market for others, 2016-2026 (USD Million)
•  
• Chapter 8. Global Oligonucleotide Synthesis Market - Regional Analysis
  • 8.1. Global oligonucleotide synthesis market: regional overview
    • 8.1.1. Global oligonucleotide synthesis market revenue share, by region, 2016 and 2026
  • 8.2. North America
    • 8.2.1. North America oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
    • 8.2.2. North America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
    • 8.2.3. North America oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.2.4.2. The U.S. oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.2.4.3. The U.S. oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.2.5. Canada
      • 8.2.5.1. Canada oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.2.5.2. Canada oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.2.5.3. Canada oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
    • 8.3.2. Europe oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
    • 8.3.3. Europe oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.3.4. UK
      • 8.3.4.1. UK oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.3.4.2. UK oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.4.3. UK oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.3.5. Germany
      • 8.3.5.1. Germany oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.3.5.2. Germany oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.5.3. Germany oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.3.6. France
      • 8.3.6.1. France oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.3.6.2. France oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.6.3. France oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.3.7. Italy
      • 8.3.7.1. Italy oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.3.7.2. Italy oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.7.3. Italy oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.3.8. Spain
      • 8.3.8.1. Spain oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.3.8.2. Spain oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.8.3. Spain oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.3.9. Rest of Europe
      • 8.3.9.1. Rest of Europe oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.3.9.2. Rest of Europe oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.3.9.3. Rest of Europe oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
    • 8.4.2. Asia Pacific oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
    • 8.4.3. Asia Pacific oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. China oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.4.4.2. China oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.4.4.3. China oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.4.5.2. Japan oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.4.5.3. Japan oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.4.6. India
      • 8.4.6.1. India oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.4.6.2. India oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.4.6.3. India oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.4.7. Southeast Asia
      • 8.4.7.1. Southeast Asia oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.4.7.2. Southeast Asia oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.4.7.3. Southeast Asia oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.4.8. Rest of Asia Pacific
      • 8.4.8.1. Rest of Asia Pacific oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.4.8.2. Rest of Asia Pacific oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.4.8.3. Rest of Asia Pacific oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
    • 8.5.2. Latin America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
    • 8.5.3. Latin America oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.5.4.2. Brazil oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.5.4.3. Brazil oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
      • 8.5.5.2. Rest of Latin America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.5.5.3. Rest of Latin America oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa oligonucleotide synthesis market revenue, by offering, 2016 - 2026 (USD Million)
    • 8.6.2. The Middle East and Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
    • 8.6.3. The Middle East and Africa oligonucleotide synthesis market revenue, by end-user, 2016 - 2026 (USD Million)
    • 8.6.4. GCC countries
      • 8.6.4.1. GCC countries oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.6.4.2. GCC countries oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.6.4.3. GCC countries oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.6.5. South Africa
      • 8.6.5.1. South Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.6.5.2. South Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.6.5.3. South Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
    • 8.6.6. Rest of the Middle East and Africa
      • 8.6.6.1. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
      • 8.6.6.2. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
      • 8.6.6.3. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Agilent Technologies, Inc.
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Product portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. ATD Bio Ltd.
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Product portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. BianoScience GmbH
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Product portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. BioSpring GmbH
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Product portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. BIONEER CORPORATION
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Product portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. Bio-Synthesis, Inc.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Product portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Creative Biogene
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Product portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. Dalton Pharma Services
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Product portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. Eurofins Genomics
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Product portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments
  • 9.10. GE
    • 9.10.1. Overview
    • 9.10.2. Financials
    • 9.10.3. Product portfolio
    • 9.10.4. Business strategy
    • 9.10.5. Recent developments
  • 9.11. GeneDesign, Inc.
    • 9.11.1. Overview
    • 9.11.2. Financials
    • 9.11.3. Product portfolio
    • 9.11.4. Business strategy
    • 9.11.5. Recent developments
  • 9.12. GenScript
    • 9.12.1. Overview
    • 9.12.2. Financials
    • 9.12.3. Product portfolio
    • 9.12.4. Business strategy
    • 9.12.5. Recent developments
  • 9.13. IBA GmbH
    • 9.13.1. Overview
    • 9.13.2. Financials
    • 9.13.3. Product portfolio
    • 9.13.4. Business strategy
    • 9.13.5. Recent developments
  • 9.14. Integrated DNA Technologies, Inc.
    • 9.14.1. Overview
    • 9.14.2. Financials
    • 9.14.3. Product portfolio
    • 9.14.4. Business strategy
    • 9.14.5. Recent developments
  • 9.15. Kaneka Eurogentec S.A.
    • 9.15.1. Overview
    • 9.15.2. Financials
    • 9.15.3. Product portfolio
    • 9.15.4. Business strategy
    • 9.15.5. Recent developments
  • 9.16. LGC Biosearch Technologies
    • 9.16.1. Overview
    • 9.16.2. Financials
    • 9.16.3. Product portfolio
    • 9.16.4. Business strategy
    • 9.16.5. Recent developments
  • 9.17. Merck KGaA
    • 9.17.1. Overview
    • 9.17.2. Financials
    • 9.17.3. Product portfolio
    • 9.17.4. Business strategy
    • 9.17.5. Recent developments
  • 9.18. Microsynth AG
    • 9.18.1. Overview
    • 9.18.2. Financials
    • 9.18.3. Product portfolio
    • 9.18.4. Business strategy
    • 9.18.5. Recent developments
  • 9.19. Syngene
    • 9.19.1. Overview
    • 9.19.2. Financials
    • 9.19.3. Product portfolio
    • 9.19.4. Business strategy
    • 9.19.5. Recent developments
  • 9.20. Thermo Fisher Scientific, Inc.
    • 9.20.1. Overview
    • 9.20.2. Financials
    • 9.20.3. Product portfolio
    • 9.20.4. Business strategy
    • 9.20.5. Recent developments
  • 9.21. TriLink BioTechnologies, LLC
    • 9.21.1. Overview
    • 9.21.2. Financials
    • 9.21.3. Product portfolio
    • 9.21.4. Business strategy
    • 9.21.5. Recent developments
  • 9.22. Twist Bioscience
    • 9.22.1. Overview
    • 9.22.2. Financials
    • 9.22.3. Product portfolio
    • 9.22.4. Business strategy
    • 9.22.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process and methodology
2. Global oligonucleotide synthesis market revenue, 2016 – 2026 (USD Million)
3. Porter’s five forces analysis
4. Oligonucleotide synthesis market attractiveness analysis, by offering 
5. Oligonucleotide synthesis market attractiveness analysis, by application 
6. Oligonucleotide synthesis market attractiveness analysis, by end-user 
7. Oligonucleotide synthesis market attractiveness analysis, by region
8. Company market share analysis, 2017
9. Global oligonucleotide synthesis market revenue share by offering, 2017 and 2026
10. Global oligonucleotide synthesis market for equipment, 2016 – 2026 (USD Million)
11. Global oligonucleotide synthesis market for reagents and consumables, 2016-2026 (USD Million)
12. Global oligonucleotide synthesis market for synthesized oligonucleotides, 2016 – 2026 (USD Million)
13. Global oligonucleotide synthesis market revenue share by application, 2017 and 2026
14. Global oligonucleotide synthesis market for research, 2016-2026 (USD Million)
15. Global oligonucleotide synthesis market for therapeutics, 2016-2026 (USD Million)
16. Global oligonucleotide synthesis market for diagnostics, 2016-2026 (USD Million)
17. Global oligonucleotide synthesis market revenue share by end-user, 2017 and 2026
18. Global oligonucleotide synthesis market for academic research institutes, 2016-2026 (USD Million)
19. Global oligonucleotide synthesis market for diagnostic laboratories, 2016 – 2026 (USD Million)
20. Global oligonucleotide synthesis market for pharmaceutical and biotechnology companies, 2016-2026 (USD Million)
21. Global oligonucleotide synthesis market for others, 2016-2026 (USD Million)
22. Global oligonucleotide synthesis market revenue share by regions, 2017 and 2026
23. North America oligonucleotide synthesis market,2016 – 2026 (USD Million)
24. Europe oligonucleotide synthesis market,2016 – 2026 (USD Million)
25. Asia Pacific oligonucleotide synthesis market,2016 – 2026 (USD Million)
26. Latin America oligonucleotide synthesis market,2016 – 2026 (USD Million)
27. The Middle East and Africa oligonucleotide synthesis market,2016 – 2026 (USD Million)
 

Table Of Tables

List of Tables

1. Oligonucleotide synthesis market: market snapshot                                                                             
2. Drivers of global oligonucleotide synthesis market: impact analysis
3. Restraints of global oligonucleotide synthesis market: impact analysis
4. North America oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
5. North America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
6. North America oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
7. The U.S. oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
8. The U.S. oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
9. The U.S. oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
10. Canada oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
11. Canada oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
12. Canada oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
13. Europe oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
14. Europe oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
15. Europe oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
16. UK oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
17. UK oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
18. UK oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
19. Germany oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
20. Germany oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
21. Germany oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
22. France oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
23. France oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
24. France oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
25. Italy oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
26. Italy oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
27. Italy oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
28. Spain oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
29. Spain oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
30. Spain oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
31. Rest of Europe oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
32. Rest of Europe oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
33. Rest of Europe oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
34. Asia Pacific oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
35. Asia Pacific oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
36. Asia Pacific oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
37. China oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
38. China oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
39. China oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
40. Japan oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
41. Japan oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
42. Japan oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
43. India oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
44. India oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
45. India oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
46. Southeast Asia oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
47. Southeast Asia oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
48. Southeast Asia oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
49. Rest of Asia Pacific oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
50. Rest of Asia Pacific oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
51. Rest of Asia Pacific oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
52. Latin America oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
53. Latin America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
54. Latin America oligonucleotide synthesis market revenue, by end-user, 2016 – 2026 (USD Million)
55. Brazil oligonucleotide synthesis market revenue, by offering, 2016 – 2026 (USD Million)
56. Brazil oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
57. Brazil oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
58. Rest of Latin America oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
59. Rest of Latin America oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
60. Rest of Latin America oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
61. The Middle East and Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
62. The Middle East and Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
63. The Middle East and Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
64. GCC countries oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
65. GCC countries oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
66. GCC countries oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
67. South Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
68. South Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
69. South Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)
70. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by offering, 2016-2026 (USD Million)
71. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by application, 2016-2026 (USD Million)
72. Rest of the Middle East and Africa oligonucleotide synthesis market revenue, by end-user, 2016-2026 (USD Million)